Navigation Links
Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
Date:12/10/2009

BEIJING, Dec. 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that effective December 1, 2009, Liang Fang, a controlled operating entity of Lotus, appointed Mr. Jinzhong HAN to be General Manager of the Company's Over-the-Counter Drug division ("OTC Division").

Mr. Han has over 20 years of medical sales experiences. Prior to joining Liang Fang, Mr. Han was General Manager of the OTC Division of Tianjin Taiping Pharmaceutical Company for two years. Prior to such time, he served approximately seven years as Vice General Manager and Chief of Marketing Officer of Beijing Yongkang Pharmaceutical Company. Mr. Han has a bachelor degree of business management from Air Force Institute of Logistics.

"Mr. Han has strong management skills in medical sales and marketing and logistics, proven with his previous tenure in both state-owned enterprises and private entities," said Dr. Zhong Yi Liu, Chairman and Chief Executive Officer of the Company. "We are bringing a strong leader to our OTC Division to further grow the OTC Division and lead a team of approximately 40 employees, of which approximately half of such employees are medical sales professionals. We are confident that Mr. Han's expertise in the area will assist the expansion of our OTC business into 2012, as well as efficiency in delivery of services to drug stores in Beijing."

About Lotus Pharmaceuticals, Inc. (http://www.lotuspharma.com )

Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Lt
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy
2. Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
3. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
4. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
5. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
6. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
7. AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
8. Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
9. Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
10. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
11. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 29, 2015 , ... Strong Animals™ announced today that ... dairy operation and presented at the ADSA-ASAS Joint Annual Meeting held July 12-16 in ... dairy cows and increased milk fat content. Also, feed containing Stay Strong™ for Dairy ...
(Date:7/28/2015)... July 28, 2015 People with a common ... achieved significant and sometimes profound improvements in their hearing ... according to a new multicenter study led by specialists ... study, described online ahead of print in the journal The ... private clinics in the United States ...
(Date:7/28/2015)... 21, 2015 Research ... addition of the "Analysis of the Global ... offering. Globally, flow cytometry remains a ... proliferation, cancer, and stem cells. But the market ... because of demand from underdeveloped nations to quantitate ...
(Date:7/28/2015)... 28, 2015 Deerfield Management Company, L.P. today ... L.P., which will invest in groundbreaking advancements in science ... cancer, and orphan diseases. The venture capital fund will ... are developed and improve the way healthcare is delivered ... largest healthcare-focused venture funds in the sector, will donate ...
Breaking Biology Technology:Strong Animals™ Announces South Dakota State University Research Demonstrates Stay Strong™ for Dairy Cows Improves Performance and Feed Stability 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... Myriant Technologies, Inc. (Myriant), a privately-held, biotech ... announced today the closing of a $60 ... Group (PTT Chemical), Thailand,s largest petrochemical producer. ... Myriant will utilize the investment for the ...
... Genomic Health, Inc. (Nasdaq: GHDX) today announced presentation ... Oncology® (ASCO®) (1) Gastrointestinal (GI) Cancer Symposium, including one ... of higher recurrence risk in stage II colon cancer, ... DX® Recurrence Score® (RS) test as well as ...
... of carbon one atom thick, graphene is like a ... 100 times the mobility they have in silicon. But ... the National Institute of Standards and Technology (NIST), because ... transforms its bustling speedway into steep hills and valleys ...
Cached Biology Technology:Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group 2Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group 3Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 3Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 4Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 5Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 6Real-world graphene devices may have a bumpy ride 2
(Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... cancer globally, and the fourth most fatal, with a ... year. The poor prognosis of pancreatic cancer patients has ... to treatment, which is not being met by the ... contains an array of products with varying molecule types ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... Coral reefs are among the ecosystems most severely threatened by ... coral species may be able to adapt to warmer oceans. ... One , an international team of researchers reports that coral ... in South-East Asian waters had previously experienced severe bleaching during ...
... that eating blueberries, blackberries, strawberries and other berry fruits ... prevent age-related memory loss and other changes, scientists report. ... fruits appears in ACS, Journal of Agricultural and ... Ph.D., and Marshall G. Miller point out that longer ...
... marine scientists made a startling discovery in the deep sea. ... surges from the seafloor and life thrives without sunlight. ... where methane rises from seeps on the ocean bottom. ... side-by-side? No one thought so. Until now. That,s ...
Cached Biology News:Global warming threat to coral reefs: Can some species adapt? 2Hot meets cold at new deep-sea ecosystem: 'Hydrothermal seep' 2
... Bioluminescence assay for monitoring acetylcholinesterase (AChE) activity. ... (less than 5 min), non-radioactive and easy ... uses the natural substrate, acetylcholine. A series ... of active AChE into a change in ...
... Kit, Linear Template is designed for use with ... No. 3 186 148, 3 186 156). The ... constructs by PCR containing and optimized control region ... RNA polymerase and prokaryotic cell lysate. Flexible positioning ...
... Roto-Shake Genie is an all-in-one rotator/rocker ... performs five different mixing motions: ... as well as a combination of ... moving portion of the Vibraotme Roto-Shake ...
... PRMT5 Arginine methylation is an irreversible ... been linked to protein activity. At least ... identified in mammalian cells. These enzymes have ... by methylation of key proteins in several ...
Biology Products: